Open Orphan plc
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker an… Read more
Market Cap & Net Worth: Open Orphan plc (OPORF)
Open Orphan plc (PINK:OPORF) has a market capitalization of $164.93 Million ($164.93 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #16916 globally and #6454 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Open Orphan plc's stock price $0.24 by its total outstanding shares 687216180 (687.22 Million).
Open Orphan plc Market Cap History: 2020 to 2025
Open Orphan plc's market capitalization history from 2020 to 2025. Data shows growth from $1.24 Million to $164.93 Million (175.22% CAGR).
Open Orphan plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Open Orphan plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.04x
Open Orphan plc's market cap is 4.04 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
23.77x
Open Orphan plc's market cap is 23.77 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.24 Million | $20.60 Million | -$10.79 Million | 0.06x | N/A |
| 2021 | $167.27 Million | $36.86 Million | -$74.00K | 4.54x | N/A |
| 2022 | $64.32 Million | $50.70 Million | -$776.00K | 1.27x | N/A |
| 2023 | $102.40 Million | $56.04 Million | $16.11 Million | 1.83x | 6.35x |
| 2024 | $253.24 Million | $62.73 Million | $10.65 Million | 4.04x | 23.77x |
Competitor Companies of OPORF by Market Capitalization
Companies near Open Orphan plc in the global market cap rankings as of March 19, 2026.
Key companies related to Open Orphan plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Open Orphan plc Historical Marketcap From 2020 to 2025
Between 2020 and today, Open Orphan plc's market cap moved from $1.24 Million to $ 164.93 Million, with a yearly change of 175.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $164.93 Million | -34.87% |
| 2024 | $253.24 Million | +147.32% |
| 2023 | $102.40 Million | +59.19% |
| 2022 | $64.32 Million | -61.54% |
| 2021 | $167.27 Million | +13422.22% |
| 2020 | $1.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Open Orphan plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $164.93 Million USD |
| MoneyControl | $164.93 Million USD |
| MarketWatch | $164.93 Million USD |
| marketcap.company | $164.93 Million USD |
| Reuters | $164.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.